Sign in

CIK 0001439725

  • Non-accelerated filer
  • Smaller reporting company

BIODESIX INC

Sign in to watch
Ticker
BDSX
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203986492
Phone
+1 303-417-0500
Business address
919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
  1. 4 Exercise or conversion Director acquired 31,619 shares (option exercise)
  2. 4 Open-market buy Director bought 10,000 shares at $1.70 ($17,000)
  3. 4 Open-market buy Director bought 20,000 shares at $1.65 ($32,952)
  4. 4 Open-market buy Director bought 189,675 shares at $1.65 ($312,945)
  5. 4 Open-market buy Director bought 67,402 shares at $1.58 ($106,529)
  6. 4 Open-market buy Director bought 100,000 shares at $1.48 ($148,380)
  7. 4 Open-market buy Director bought 130,434 shares at $1.15 ($149,999)
  8. 4 Open-market buy Director bought 43,478 shares at $1.15 ($50,000)
  9. 4 Open-market buy Director bought 1,739,130 shares at $1.15 ($2,000,000)
  10. 4 Open-market buy Director bought 8,695,652 shares at $1.15 ($10,000,000)
  11. 4 Grant or award Chief Accounting Officer acquired 8,695 shares (grant or award)
  12. 4 Grant or award President & CEO acquired 65,217 shares (grant or award)
  13. 4 Grant or award Chief Commercial Officer acquired 4,347 shares (grant or award)
  14. 4 Open-market buy Director bought 2,669,562 shares at $1.15 ($3,069,996)
  15. 4 Open-market buy Director bought 173,913 shares at $1.15 ($200,000)
  16. 4 Grant or award Chief Scientific Officer acquired 12,000 shares (grant or award)
  17. 4 Grant or award CFO, Sec'y & Treasurer acquired 17,391 shares (grant or award)
  18. 4 Open-market sale Chief Commercial Officer sold 1,705 shares at an average $1.03 ($1,758)
  19. 4 Open-market sale Chief Scientific Officer sold 1,776 shares at an average $1.03 ($1,831)
  20. 4 Open-market sale President & CEO sold 13,777 shares at an average $1.03 ($14,205)

Page 12 of 17 · 336 filings